Paper41003423
Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K.
Crintea A and 4 others. J Funct Biomater, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K. Papers, record 41003423. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003423
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bio-Functional Nanomaterials for Enhanced Lung Cancer Therapy: The Synergistic Roles of Vitamins D and K.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References228
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37814270 | Progressing nanotechnology to improve targeted cancer treatment: overcoming hurdles in its clinical implementation. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37814270 | PubMed |
| 2 | 40575656 | Advancing cancer therapy: Nanomaterial-based encapsulation strategies for enhanced delivery and efficacy of curcumin. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/40575656 | PubMed |
| 3 | 38065446 | Targeted drug delivery systems for matrix metalloproteinase-responsive anoparticles in tumor cells: A review. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/38065446 | PubMed |
| 4 | 37324805 | Stimuli-responsive crosslinked nanomedicine for cancer treatment. | Exploration (Beijing) | 2022 | https://conductscience.org/library/papers/37324805 | PubMed |
| 5 | 21872801 | The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃. | Best Pract Res Clin Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21872801 | PubMed |
| 6 | 37836529 | Cancer Metabolism as a Therapeutic Target and Review of Interventions. | Nutrients | 2023 | https://conductscience.org/library/papers/37836529 | PubMed |
| 7 | 36770535 | Nanoparticles: Taking a Unique Position in Medicine. | Nanomaterials (Basel) | 2023 | https://conductscience.org/library/papers/36770535 | PubMed |
| 8 | 35458084 | Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/35458084 | PubMed |
| 9 | 36313628 | The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36313628 | PubMed |
| 10 | 39796653 | Preclinical Models for Functional Precision Lung Cancer Research. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39796653 | PubMed |
| 11 | 24084056 | Molecular link between vitamin D and cancer prevention. | Nutrients | 2013 | https://conductscience.org/library/papers/24084056 | PubMed |
| 12 | 39861782 | Nanosuspension Innovations: Expanding Horizons in Drug Delivery Techniques. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/39861782 | PubMed |
| 13 | 35213980 | The Hitchhiker's Guide to Human Therapeutic Nanoparticle Development. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/35213980 | PubMed |
| 14 | 37049850 | Metal Oxides Nanoparticles: General Structural Description, Chemical, Physical, and Biological Synthesis Methods, Role in Pesticides and Heavy Metal Removal through Wastewater Treatment. | Molecules | 2023 | https://conductscience.org/library/papers/37049850 | PubMed |
| 15 | 22263017 | Epidermal growth factor receptor (EGFR) in lung cancer: an overview and update. | J Thorac Dis | 2010 | https://conductscience.org/library/papers/22263017 | PubMed |
| 16 | 39339402 | Targeted Drug Delivery Strategies for the Treatment of Hepatocellular Carcinoma. | Molecules | 2024 | https://conductscience.org/library/papers/39339402 | PubMed |
| 17 | 27349465 | Temperature-Responsive Smart Nanocarriers for Delivery Of Therapeutic Agents: Applications and Recent Advances. | ACS Appl Mater Interfaces | 2016 | https://conductscience.org/library/papers/27349465 | PubMed |
| 18 | 28698808 | Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health. | J Nutr Metab | 2017 | https://conductscience.org/library/papers/28698808 | PubMed |
| 19 | 23298335 | Association between dietary phylloquinone intake and peripheral metabolic risk markers related to insulin resistance and diabetes in elderly subjects at high cardiovascular risk. | Cardiovasc Diabetol | 2013 | https://conductscience.org/library/papers/23298335 | PubMed |
| 20 | 35008569 | Matrix Metalloproteinases Shape the Tumor Microenvironment in Cancer Progression. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/35008569 | PubMed |
Genes39
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41003423
GET https://conductscience.org/api/papers/v1/41003423/references?page=2